Your cart

There are no items in your shopping cart

ODM-207

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 3329

CAS [1801503-93-4]

MF C22H21N3O3
MW 375.42

  • Purity: 99%
  • Soluble in DMSO

ODM-207

Description

ODM-207 is a highly potent, selective and orally active pan-BET inhibitor that has shown preclinical evidence of tumour growth inhibition in breast cancer and in leukaemia and prostate cancer xenograft models.

KEYWORDS: ODM-207 | supplier | BET inhibitor | ODM207 | ODM 207 | CAS [1801503-93-4] | Histone | BET (BRD) | Inhibitor | Proteins | Prostate cancer | Breast cancer

Order
Size Unit Price Stock
5 mg €140.00 In Stock
25 mg €490.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €220.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
1887 PFI-1 BET bromodomain (BRD) inhibitor €75.00
1989 (+)-JQ1

Potent and selective BET bromodomain inhibitor

 €60.00
2245 RVX 208 BET bromodomain inhibitor specific for second bromodomains (BD2s) €65.00
2530 OTX 015 Potent inhibitor of BRD2, BRD3, and BRD4 with clear anti-proliferative activity €110.00
2594 CPI 0610 Selective and metabolically stable inhibitor of BET bromodomains Inquire
2776 CD161 Potent, selective, and orally active BET bromodomain inhibitor €135.00
3037 BI-894999 Potent, selective and orally active BET inhibitor €165.00
3623 SGC-SMARCA-BRDVIII Potent, highly selective and cell-active SMARCA2/4 and PB1(5) bromodomain inhibitor €90.00
3716 BMS-986158 BET bromodomain (BRD) inhibitor Inquire
3696 ABBV-075 Highly potent and orally bioavailable BET bromodomain (BRD) inhibitor €110.00
3860 I-BET726 Potent and selective, tetrahydroquinoline-based small molecule ligand binding to BET proteins Inquire
3822 (+)-JQ1 carboxylic acid (+)-JQ1 derivative; PROTAC precursor €110.00
3921 GSK046 Domain-selective and orally active inhibitor of BET with immunomodulatory activity Inquire
3922 dBET1 BET bromodomain degrader Inquire
3944 ARV-825 Potent and selective protein BRD4 degrader Inquire
3956 ABBV-744 First-in-class highly BDII (Bromodomain II)-selective BET bromodomain inhibitor Inquire
3873 (-)-JQ-1 Inactive enantiomer of (+)-JQ1  Recently added €120.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...